文献速递消化系统肿瘤

腹膜间皮瘤的分子特征研究

Molecular Characterization of Peritoneal Mesotheliomas.
PubMed 文献 · J Thorac Oncol · 2021-10-11

该研究对50例恶性腹膜间皮瘤(MPeM)患者的前瞻性队列进行二代测序和免疫组化分析,发现BAP1(60%)、NF2(24%)、SETD2(22%)和TP53(16%)为常见基因改变,CDKN2A/B改变罕见;BAP1改变或缺失与更短的总生存相关(43.8 vs 117.3个月,p=0.04),3/30例存在致病性胚系变异。

要点

  • MPeM常见BAP1、NF2、SETD2和TP53改变,CDKN2A/B改变罕见。
  • BAP1改变或缺失与更短的总生存相关。
  • BAP1免疫组化缺失占76%,其中5例NGS为野生型。

核心结论

  • MPeM具有独特的生物学和基因组组成,BAP1改变或缺失与更短的总生存相关。

研究设计与样本

  • 前瞻性收集50例MPeM患者(45例上皮样,5例非上皮样),对肿瘤进行二代测序和免疫组化评估。

主要发现

  • BAP1改变占60%(30/50),NF2占24%(12/50),SETD2占22%(11/50),TP53占16%(8/50)。
  • 可评估等位基因特异性拷贝数分析的38例中,8%(3/38)存在基因组近单倍体化(GNH)。
  • 免疫组化阳性率:间皮素93%(37/40),WT1 96%(46/48),PD-L1 50%(19/38),VISTA 89%(34/38)。
  • BAP1免疫组化缺失占76%(29/38),其中5例NGS为野生型。
  • 结合NGS和IHC,BAP1改变或缺失患者总生存更差(37例 vs 13例,43.8 vs 117.3个月,p=0.04)。

临床怎么用

  • 对MPeM患者可考虑进行BAP1免疫组化和二代测序以评估预后。

局限性

  • 样本量较小(50例),部分分析可评估例数有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Malignant peritoneal mesothelioma (MPeM) is clinically distinct and less studied than malignant pleural mesothelioma. We report the genomic and immunophenotypic features of a prospectively collected MPeM cohort. METHODS: Next-generation sequencing (NGS) was performed on MPeM tumors. Genomic near-haploidization (GNH) was assessed. WT1, BAP1, mesothelin, VISTA, and programmed death-ligand 1 were evaluated by immunohistochemistry (IHC) when tissue was available. Overall survival was stratified by selected genomic and IHC features. RESULTS: A total of 50 consented patients with MPeM (45 epithelioid, 5 nonepithelioid) were studied exhibiting common alterations in BAP1 (60%; 30 of 50), NF2 (24%; 12 of 50) SETD2 (22%; 11 of 50), and TP53 (16%; 8 of 50). A total of 76% (38 of 50) of specimens were assessable for allele-specific copy number analysis; 8% (3 of 38) had GNH. IHC positivity rates were 93% (37 of 40) for mesothelin, 96% (46 of 48) for WT1, 50% (19 of 38) for programmed death-ligand 1, and 89% (34 of 38) for VISTA. BAP1 loss by IHC was observed in 76% (29 of 38), including five wild-type on NGS. Combining NGS and IHC for BAP1, overall survival was worse with alteration or loss compared with wild-type or retained in all patients (n = 37 versus 13, 43.8 versus 117.3 mo, p = 0.04) Three of 30 patients had a pathogenic germline variant: POT1 I78T, MUTYH R109Y, and BAP1 E402∗. CONCLUSIONS: MPeM has distinct biology and genomic composition. CDKN2A/B alterations were rare in MPeM, whereas BAP1, NF2, TP53, SETD2, and LATS2 were common. BAP1 alteration/loss was associated with shorter survival when all patients were included. A notable minority of specimens had GNH associated with NF2, TP53, and SETDB1 mutations. Pathogenic germline mutations were found in 3 of 30 patients.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Offin M, Yang SR, Egger J, et al. Molecular Characterization of Peritoneal Mesotheliomas. J Thorac Oncol. 2021. PMID: 34648949. doi:10.1016/j.jtho.2021.09.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。